Clinical trial AB11002
AB11002 A prospective, multicenter, randomized, open-label, active-controlled, 2-parallel group, phase III study to compare efficacy and safety of masitinib to sunitinib in patients with gastrointestinla stromal tumor after progression with imatinib.
| Cancers | |
|---|---|
| Organ | Stomach - Duodenum-esogastric junction |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | AB Science |
| EudraCT Identifier | 2011-00179-041 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01694277 |
| Inclusion criteria | c-Kit positive. Progression under imatinib |
| Last update |